Literature DB >> 22016435

Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study.

Cheng-Ta Li1, Ya-Mei Bai, Yu-Lin Huang, Ying-Sheue Chen, Tzeng-Ji Chen, Ju-Yin Cheng, Tung-Ping Su.   

Abstract

BACKGROUND: People with major depressive disorder who fail to respond to adequate trials of antidepressant treatment may harbour hidden bipolar disorder. AIMS: We aimed to compare the rates of a change in diagnosis to bipolar disorder among people with major depressive disorder with stratified responses to antidepressants during an 8-year follow-up period.
METHOD: Information on individuals with major depressive disorder identified during 2000 (cohort 2000, n = 1485) and 2003 (cohort 2003, n = 2459) were collected from a nationally representative cohort of 1,000,000 health service users in Taiwan. Participants responding well to antidepressants were compared with those showing poor responses to adequate trials of antidepressants.
RESULTS: In 7.6-12.1% of those with a diagnosis of unipolar major depressive disorder this diagnosis was subsequently changed to bipolar disorder, with a mean time to change of 1.89-2.98 years. Difficult-to-treat participants presented higher rates of change to a bipolar diagnosis (25.6% in cohort 2000; 26.6% in cohort 2003) than easy-to-treat participants (8.8-8.9% in cohort 2000; 6.8-8.6% in cohort 2003; P<0.0001). Regression analysis showed that the variable most strongly associated with the change in diagnosis was antidepressant use history. The difficult-to-treat participants were associated most with diagnostic changing (cohort 2000: odds ratio (OR) = 1.88 (95% CI 1.12-3.16); cohort 2003: OR = 4.94 (95% CI 2.81-8.68)).
CONCLUSIONS: This is the first large-scale study to report an association between antidepressant response history and subsequent change in diagnosis from major depressive disorder to bipolar disorder. Our findings support the view that a history of poor response to antidepressants in unipolar depression could be a useful predictor for bipolar diathesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016435     DOI: 10.1192/bjp.bp.110.086983

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  33 in total

1.  High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression.

Authors:  Cheng-Ta Li; Ya-Mei Bai; Ying-Chiao Lee; Wei-Chung Mao; Mu-Hong Chen; Pei-Chi Tu; Ying-Sheue Chen; Tzeng-Ji Chen; Wen-Hang Chang; Tung-Ping Su
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

2.  Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial.

Authors:  Diego F Tavares; Martin L Myczkowski; Rodrigo L Alberto; Leandro Valiengo; Rosa M Rios; Pedro Gordon; Bernardo de Sampaio-Junior; Izio Klein; Carlos G Mansur; Marco Antonio Marcolin; Beny Lafer; Ricardo A Moreno; Wagner Gattaz; Zafiris J Daskalakis; André R Brunoni
Journal:  Neuropsychopharmacology       Date:  2017-02-01       Impact factor: 7.853

3.  Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study.

Authors:  Cheng-Ta Li; Ya-Mei Bai; Pei-Chi Tu; Ying-Chiao Lee; Yu-Lin Huang; Tzeng-Ji Chen; Wen-Han Chang; Tung-Ping Su
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Timing of the Diagnoses of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder in Taiwan.

Authors:  Han-Ting Wei; Ju-Wei Hsu; Kai-Lin Huang; Ya-Mei Bai; Tung-Ping Su; Cheng-Ta Li; Wei-Chen Lin; Shih-Jen Tsai; Tai-Long Pan; Tzeng-Ji Chen; Mu-Hong Chen
Journal:  J Autism Dev Disord       Date:  2021-03

5.  Power behind the throne: A clinical trial simulation study evaluating the impact of controllable design factors on the power of antidepressant trials.

Authors:  Astrid Chevance; Florian Naudet; Raphaël Gaillard; Philippe Ravaud; Raphaël Porcher
Journal:  Int J Methods Psychiatr Res       Date:  2019-04-17       Impact factor: 4.035

6.  The Risk of Sexually Transmitted Infections Following First-Episode Schizophrenia Among Adolescents and Young Adults: A Cohort Study of 220 545 Subjects.

Authors:  Chih-Sung Liang; Ya-Mei Bai; Ju-Wei Hsu; Kai-Lin Huang; Nai-Ying Ko; Hsuan-Te Chu; Ta-Chuan Yeh; Shih-Jen Tsai; Tzeng-Ji Chen; Mu-Hong Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 7.  An update on antidepressant use in bipolar depression.

Authors:  Michelle M Sidor; Glenda M MacQueen
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 8.  Options for pharmacological treatment of refractory bipolar depression.

Authors:  Leonardo Tondo; Gustavo H Vázquez; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

Review 9.  Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.

Authors:  Renske C Bosman; Ruth C Waumans; Gabriel E Jacobs; Richard C Oude Voshaar; Anna D T Muntingh; Neeltje M Batelaan; Anton J L M van Balkom
Journal:  Psychother Psychosom       Date:  2018-07-24       Impact factor: 17.659

10.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.